Drimva

NewLimit

Scientist, Metabolism

$130K–$165K

South San Francisco +1 · Full-time · Posted Sep 25, 2026

Location
South San Francisco
South San Francisco, California, United States
Experience
5+ years of equivalent industry experience is stated as an alternative to a Ph.D.; no separate years requirement is given.
Education
Ph.D. in cell biology, molecular biology, biochemistry, or a related field, or equivalent industry experience.

About the job

Develop and evaluate epigenetic reprogramming interventions and assays to restore hepatocyte function in age-related and metabolic liver disease.

What you'll do

  • Develop assays and use preclinical liver disease models to measure hepatocyte function and evaluate therapeutic candidates.
  • Deliver reprogramming perturbations to hepatocytes in vivo using transgenic manipulation methods, and analyze results to guide preclinical decisions.
  • Collaborate across teams to design, build, and test interventions for aged and diseased hepatocytes.

What they ask for

  • Ph.D. in cell biology, molecular biology, biochemistry, or a related field, or equivalent industry experience (5+ years).
  • Experience with primary liver cell isolation and functional characterization.
  • Experience working with mouse models of liver dysfunction.
  • Experience with transgenic manipulation of liver cells ex vivo or in vivo, such as viral vectors or nucleic acid delivery.

Nice to have

  • Contributed to a preclinical or clinical drug development program; or led preclinical mouse studies.
  • Experience with single cell genomics or pooled screening approaches.

Pay

$130,000 to $165,000 (base salary)

Tools

viral vectors, lipid nanoparticles, CRISPR fitness screens, Perturb/CROP-seq

Model-written summary · the original posting is authoritative

First seen Oct 29, 2026 · Last verified Nov 5, 2026 (UTC)